|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
|
Babson College
1-Year MBA |
Admitted, ($)
|
2023 | 640 GMAT Classic | 3 | 1 | India |
02 Dec 2022 08:26 AM
|
||
|
Nanyang MBA
Full Time MBA |
Admitted
|
2023 | 750 GMAT Classic | 4 | 15 | Healthcare/Pharmaceuticals | India |
02 Dec 2022 04:01 AM
|
|
|
Columbia
Full Time MBA |
Waitlisted with Interview
|
Early Decision | 2023 | 750 GMAT Classic | 1 | 6 | Russian Federation |
02 Dec 2022 01:51 AM
|
|
|
LBS
Full Time MBA |
Admitted
|
2023 | 700 GMAT Classic | 3.8 | 4 | Thailand |
02 Dec 2022 12:29 AM
|
||
|
Booth
Full Time MBA |
Admitted, ($$$)
|
Round 1 | 2023 | 334 GRE | 3.5 | 0 | Nigeria |
02 Dec 2022 12:10 AM
|
|
|
Sauder
Full Time MBA |
Withdrawn Application
|
2023 | 670 GMAT Classic | 3.5 | 6 | Transportation | India |
01 Dec 2022 11:40 PM
|
|
|
Booth
Full Time MBA |
Admitted, ($$)
|
Round 1 | 2023 | 740 GMAT Classic | 3.6 | 4 | United States |
01 Dec 2022 11:11 PM
|
|
|
Booth
Full Time MBA |
Admitted
|
Round 1 | 2023 | 710 GMAT Classic | Korea, Republic of |
01 Dec 2022 07:43 PM
|
|||
|
Harvard
Full Time MBA |
Denied without Interview
|
Round 1 | 2023 | 335 GRE | 3.1 | 1 | Nigeria |
01 Dec 2022 07:13 PM
|
|
|
Booth
Full Time MBA |
Admitted, ($$)
|
Round 1 | 2023 | 335 GRE | 3.1 | 1 | Nigeria |
01 Dec 2022 07:05 PM
|
|
|
Booth
Full Time MBA |
Admitted
|
Round 1 | 2023 | 3.6 | 4 | Healthcare/Pharmaceuticals | France |
01 Dec 2022 04:14 PM
|
|
|
LBS
Full Time MBA |
Admitted
|
2023 | 328 GRE | 4 | 4 | India |
01 Dec 2022 02:16 PM
|
||
|
Booth
Full Time MBA |
Admitted, ($$$)
|
Round 1 | 2023 | 750 GMAT Classic | 4 | 3 | United States |
01 Dec 2022 02:13 PM
|
|
|
Booth
Full Time MBA |
Admitted, ($$)
|
Round 1 | 2023 | 730 GMAT Classic | 3.3 | 7 | United States |
01 Dec 2022 11:33 AM
|
|
|
Booth
Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2023 | 730 GMAT Classic | 3.6 | 4 | Consulting | United States |
01 Dec 2022 11:17 AM
|
|
Booth
Full Time MBA |
Admitted
|
Round 1 | 2023 | 730 GMAT Classic | 3.9 | 4 | Consulting | China |
01 Dec 2022 10:39 AM
|
|
Booth
Full Time MBA |
Admitted
|
Round 1 | 2023 | 4 | 4 | Pharmaceuticals and Biotech | United States |
01 Dec 2022 10:08 AM
|
|
|
LBS
Full Time MBA |
Waitlisted with Interview
|
2023 | 730 GMAT Classic | 3.3 | 7 | United States |
01 Dec 2022 06:41 AM
|
||
|
LBS
Full Time MBA |
Waitlisted with Interview
|
2023 | 760 GMAT Classic | 3.9 | 6 | Consulting | India |
01 Dec 2022 06:07 AM
|
|
|
Booth
Full Time MBA |
Interviewed
|
Round 1 | 2023 | 700 GMAT Classic | 3.8 | 0 | China |
30 Nov 2022 09:22 PM
|